Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of copy-number variants in patients with overgrowth disorders.
Parra A, Tenorio-Castano J, Nevado J, Cazalla M, Miranda-Alcaraz L, Gallego-Zazo N, Silván C, Arias P, Pozo-Román J, Ballesta-Martínez MJ, Guillén-Navarro E, Arroyo I, Lotersztein V, Cosentino V, González-Meneses A, Galán E, Rosell J, Ramos F; Spanish OverGrowth Registry Initiative; Lapunzina P. Parra A, et al. Clin Genet. 2024 Nov;106(5):614-624. doi: 10.1111/cge.14596. Epub 2024 Aug 1. Clin Genet. 2024. PMID: 39091142
Hematological Composite Scores in Patients with Inflammatory Bowel Disease.
Carrillo-Palau M, Vera-Santana B, Morant-Domínguez A, Hernández-Camba A, Ramos L, Alonso-Abreu I, Hernández Álvarez-Buylla N, Arranz L, Vela M, Hernández-Guerra M, Gómez-Moreno C, González-Gay MÁ, Ferraz-Amaro I. Carrillo-Palau M, et al. Among authors: arranz l. J Clin Med. 2023 Nov 23;12(23):7248. doi: 10.3390/jcm12237248. J Clin Med. 2023. PMID: 38068300 Free PMC article.
Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry.
García MJ, Rivero M, Fernández-Clotet A, de Francisco R, Sicilia B, Mesonero F, de Castro ML, Casanova MJ, Bertoletti F, García-Alonso FJ, López-García A, Vicente R, Calvet X, Barreiro-de Acosta M, Ferrer Rosique J, Varela Trastoy P, Nuñez A, Ricart E, Riestra S, Arias García L, Rodríguez M, Arranz L, Pajares R, Mena R, Calafat M, Camo P, Bermejo F, Ponferrada Á, Madrigal RE, Llaó J, Sesé E, Sánchez E, Pineda Mariño JR, González Muñoza C, Carbajo López AY, Julián AB, Villoria Ferrer A, Baston-Rey I, Jara L, Almela P, Codesido L, de la Maza S, Leal C, Caballol B, Pérez-Martínez I, Vinuesa Campo R, Crespo J, Domènech E, Chaparro M, Gisbert JP. García MJ, et al. Among authors: arranz l. J Crohns Colitis. 2024 Jan 27;18(1):65-74. doi: 10.1093/ecco-jcc/jjad124. J Crohns Colitis. 2024. PMID: 37522878
Author Correction: Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation.
Villatoro A, Cuminetti V, Bernal A, Torroja C, Cossío I, Benguría A, Ferré M, Konieczny J, Vázquez E, Rubio A, Utnes P, Tello A, You X, Fenton CG, Paulssen RH, Zhang J, Sánchez-Cabo F, Dopazo A, Vik A, Anderssen E, Hidalgo A, Arranz L. Villatoro A, et al. Among authors: arranz l. Nat Commun. 2023 Jun 30;14(1):3874. doi: 10.1038/s41467-023-39601-3. Nat Commun. 2023. PMID: 37391415 Free PMC article. No abstract available.
Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation.
Villatoro A, Cuminetti V, Bernal A, Torroja C, Cossío I, Benguría A, Ferré M, Konieczny J, Vázquez E, Rubio A, Utnes P, Tello A, You X, Fenton CG, Paulssen RH, Zhang J, Sánchez-Cabo F, Dopazo A, Vik A, Anderssen E, Hidalgo A, Arranz L. Villatoro A, et al. Among authors: arranz l. Nat Commun. 2023 Jan 3;14(1):12. doi: 10.1038/s41467-022-35700-9. Nat Commun. 2023. PMID: 36596811 Free PMC article.
Crosstalk between AML and stromal cells triggers acetate secretion through the metabolic rewiring of stromal cells.
Vilaplana-Lopera N, Cuminetti V, Almaghrabi R, Papatzikas G, Rout AK, Jeeves M, González E, Alyahyawi Y, Cunningham A, Erdem A, Schnütgen F, Raghavan M, Potluri S, Cazier JB, Schuringa JJ, Reed MAC, Arranz L, Günther UL, Garcia P. Vilaplana-Lopera N, et al. Among authors: arranz l. Elife. 2022 Sep 2;11:e75908. doi: 10.7554/eLife.75908. Elife. 2022. PMID: 36052997 Free PMC article.
Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU.
Riestra S, Taxonera C, Zabana Y, Carpio D, Chaparro M, Barrio J, Rivero M, López-Sanroman A, Esteve M, de Francisco R, Bastida G, García-López S, Mañosa M, Martin-Arranz MD, Pérez-Calle JL, Guardiola J, Muñoz F, Arranz L, Cabriada JL, García-Sepulcre MF, Navarro M, Montoro-Huguet MÁ, Ricart E, Bermejo F, Calvet X, Piqueras M, Garcia-Planella E, Márquez L, Mínguez M, Van Domselar M, Bujanda L, Aldeguer X, Sicilia B, Iglesias E, Alcaín G, Pérez-Martínez I, Rolle V, Castaño-García A, P Gisbert J, Domènech E, On Behalf Of The Eneida Registry From Geteccu. Riestra S, et al. Among authors: arranz l. J Clin Med. 2022 Jul 5;11(13):3915. doi: 10.3390/jcm11133915. J Clin Med. 2022. PMID: 35807201 Free PMC article.
Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease.
Hernández-Camba A, Carrillo-Palau M, Ramos L, de Armas-Rillo L, Vela M, Arranz L, González-Gay MÁ, Ferraz-Amaro I. Hernández-Camba A, et al. Among authors: arranz l. Clin Transl Gastroenterol. 2022 Jun 1;13(6):e00500. doi: 10.14309/ctg.0000000000000500. Clin Transl Gastroenterol. 2022. PMID: 35584319 Free PMC article.
84 results